New Hope for Pancreatic Cancer Patients

A breakthrough treatment for pancreatic cancer could double life expectancy from 6.7 to 13 months, offering precious extra time with loved ones. Though not a cure and still awaiting full FDA approval, the drug is already available through an expanded access program. Advocacy groups like Polly’s Run have raised record funds to support this research, showing community commitment. Early studies also hint at potential applications for ovarian, colon, and lung cancers, turning a ray of hope into a growing movement. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/a4c7e5fef3852066